Mineralys Therapeutics (MLYS) EPS (Basic) (2022 - 2026)
Mineralys Therapeutics (MLYS) reported EPS (Basic) of -$0.55 for Q1 2026, up 34.53% on a YoY basis from -$0.41 in Q1 2025, and up 79.94% sequentially from -$2.73 in Q4 2025.
Mineralys Therapeutics (MLYS) EPS (Basic) (2022 - 2026) Analysis & Trends
Mineralys Therapeutics (MLYS) has 5 years of EPS (Basic) data on file, last reported at -$0.55 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) rose 34.53% year-over-year to -$0.55; the trailing twelve-month figure through Mar 2026 stood at -$3.84 (up 27.52% YoY), and the FY2025 full-year result was -$4.68, up 16.51% from the prior year.
- EPS (Basic) rose to -$0.55 in Q1 2026, from -$2.73 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.4 in Q2 2023 to a low of -$4.95 in Q4 2022.
- A 5-year average of -$1.33 and a median of -$0.84 in 2025 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) surged 84.05% in 2023 and sank 243.69% in 2024, its largest moves.
- Tracing MLYS's EPS (Basic) over 5 years: stood at -$4.95 in 2022, then surged by 84.05% to -$0.79 in 2023, then tumbled by 243.69% to -$2.71 in 2024, then fell by 0.57% to -$2.73 in 2025, then jumped by 79.94% to -$0.55 in 2026.
- Business Quant data shows MLYS's EPS (Basic) at -$0.55 in Q1 2026, -$2.73 in Q4 2025, and -$0.58 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Mineralys Therapeutics | 2.24 Bn | 2.24 Bn | - | -0.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.55 |
| Dec 31, 2025 | -2.73 |
| Sep 30, 2025 | -0.58 |
| Jun 30, 2025 | -0.71 |
| Mar 31, 2025 | -0.84 |
| Dec 31, 2024 | -2.71 |
| Sep 30, 2024 | -1.21 |
| Jun 30, 2024 | -0.92 |
| Mar 31, 2024 | -0.79 |
| Dec 31, 2023 | -0.79 |
| Sep 30, 2023 | -0.66 |
| Jun 30, 2023 | -0.40 |
| Mar 31, 2023 | -0.60 |
| Dec 31, 2022 | -4.95 |
| Sep 30, 2022 | -1.43 |
| Jun 30, 2022 | -1.26 |
| Mar 31, 2022 | -1.48 |